Systemic Lupus Erythematosus2
-
Upload
mark-christian-m-gonzaga -
Category
Documents
-
view
216 -
download
0
Transcript of Systemic Lupus Erythematosus2
-
8/13/2019 Systemic Lupus Erythematosus2
1/34
Systemic Lupus Erythematosus
Daniel Ryan M. Arriola II
-
8/13/2019 Systemic Lupus Erythematosus2
2/34
Background Information
Overall prevalence of SLE isestimated to be 1 per 2500 persons
Occurs 10 times more frequently in
women than in men and
approximately three times more
frequently in African Americans than inCaucasians
-
8/13/2019 Systemic Lupus Erythematosus2
3/34
Background Information
Unknown cause
Tissues and Cells are damaged by
immune system
Lupus literally means wolf - lesions of
skin
Erythematosusredness of the skin
due to inflammation
-
8/13/2019 Systemic Lupus Erythematosus2
4/34
Background Information
Systemicnot confined in the skin butcan affect tissues and cells all through
out the body
Another systemic effect is the presence of
low grade fever in most cases of SLE
-
8/13/2019 Systemic Lupus Erythematosus2
5/34
Background Information
Autoimmune disorder
Combination of self antibodies with
self-antigen forms immune complexes
Inflammation and tissue destructions
Multisystemcan affect different
systems of the body
-
8/13/2019 Systemic Lupus Erythematosus2
6/34
Autoimmmune or Connective Tissue
Disorders
An illness that occurs when the body isattacked by its own immune system.
The bodys immune system malfunctions
and produces large amounts of harmfulsubstances called autoantibodies.
Autoantibodies, unlike normal antibodies
that target foreign invaders such asviruses and bacteria, attack the bodiesown tissue and cells.
-
8/13/2019 Systemic Lupus Erythematosus2
7/34
Autoantibodies
Autoantibody-mediated inflammationand cell damage and destruction can
affect blood cells, skin, joints, kidneys,
lungs, nervous system, and otherorgans of the body.
-
8/13/2019 Systemic Lupus Erythematosus2
8/34
Development of Autoimmunity
-
8/13/2019 Systemic Lupus Erythematosus2
9/34
-
8/13/2019 Systemic Lupus Erythematosus2
10/34
PATHOPHYSIOLOGY
-
8/13/2019 Systemic Lupus Erythematosus2
11/34
Predisposing Factors
Genetic Predisposition
Gender
Environmental stimuli start Immune
Responses
Autoantibodies Appear through
autoimmunity
-
8/13/2019 Systemic Lupus Erythematosus2
12/34
Regulation of theAutoantibodies Fails:Clinical disease
Chronic inflammation and progressive
damage
-
8/13/2019 Systemic Lupus Erythematosus2
13/34
Formation of Auotantibodies
Specifically, B cells and T cells both
contribute to the immune response inSLE. B cells are instrumental in
promoting the onset and flares of the
disease
Clinical Manifestations
-
8/13/2019 Systemic Lupus Erythematosus2
14/34
CLINICALMANIFESTATIONS
-
8/13/2019 Systemic Lupus Erythematosus2
15/34
The Joints and Muscles
Involvement of the musculoskeletalsystem, with arthralgias and arthritis,
is a common presenting feature of
SLE Joint swelling, tenderness, and pain
on movement are also common
Frequently, these are accompanied bymorning stiffness
Onset of disease may be insidious or
acute
-
8/13/2019 Systemic Lupus Erythematosus2
16/34
-
8/13/2019 Systemic Lupus Erythematosus2
17/34
-
8/13/2019 Systemic Lupus Erythematosus2
18/34
The Skin
Several different types of skinmanifestations may occur in pts withSLE, including subacute cutaneouslupus erythematosus, which involvespapulosquamous or annular polycycliclesions, and discoid lupuserythematosus, which is a chronic
rash that has erythematous papules orplaques and scaling and can causescarring and pigmentation changes
-
8/13/2019 Systemic Lupus Erythematosus2
19/34
The Skin Cont.
The most familiar skin manifestation(occurring in more than 50% of pts
with SLE) is an acute cutaneous
lesion consisting of a butterfly-shapedrash across the bridge of the nose and
cheeks
In some cases of discoid lupuserythematosus, only skin involvement
occurs
-
8/13/2019 Systemic Lupus Erythematosus2
20/34
The Skin Cont.
In some pts with SLE, the initial skininvolvement is the precursor to more
systemic involvement
The lesions often worsen duringexacerbations (flares) of the systemic
disease and possibly are provoked by
sunlight or artificial ultraviolet light
-
8/13/2019 Systemic Lupus Erythematosus2
21/34
-
8/13/2019 Systemic Lupus Erythematosus2
22/34
Malar or Butterfly Rash
-
8/13/2019 Systemic Lupus Erythematosus2
23/34
Acute Cutaneous: Malar Rash
Note Sparing of Nasolabial Folds
-
8/13/2019 Systemic Lupus Erythematosus2
24/34
Chronic
Cutaneous:
Discoid
Note Scarring,
Hyperpigment
-ation
-
8/13/2019 Systemic Lupus Erythematosus2
25/34
Discoid RashStimulated by UV light
-
8/13/2019 Systemic Lupus Erythematosus2
26/34
Livedo Reticularis
-
8/13/2019 Systemic Lupus Erythematosus2
27/34
-
8/13/2019 Systemic Lupus Erythematosus2
28/34
Cardiovascular
Pericarditis is the most commoncardiac manifestation
Women who have SLE are also at risk
for early atherosclerosis
-
8/13/2019 Systemic Lupus Erythematosus2
29/34
Urinary
Serum creatinine levels and urinalysisare used in screening for renal
involvement
Early detection allows for prompttreatment so that renal damage can
be prevented
Renal involvement may lead tohypertension, which also requires
careful monitoring and management
-
8/13/2019 Systemic Lupus Erythematosus2
30/34
Central Nervous System
Central nervous involvement iswidespread, encompassing the entire
range of neurologic disease.
The varied and frequentneuropsychiatric presentations of SLE
are now widely recognized. These are
generally demonstrated by subtlechanges in behavior patterns or
cognitive ability.
-
8/13/2019 Systemic Lupus Erythematosus2
31/34
Endocrine
Sex hormone may play a role in SLEbecause 90% of the cases occur in
female and females with SLE have
reduced levels of androgens
-
8/13/2019 Systemic Lupus Erythematosus2
32/34
Respiratory
Chest pain caused by inflammation ofpleural membranes, fever, SOB and
hypoxemia
-
8/13/2019 Systemic Lupus Erythematosus2
33/34
Digestive
Ulcers may develop in the oral cavityand pharynx
Abdominal pain and vomiting may
occur No cause can be found
Inflammation of the pancreas
Occasionally enlargement of the liver
-
8/13/2019 Systemic Lupus Erythematosus2
34/34
Thank you